标题
Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
作者
关键词
-
出版物
Pharmaceutics
Volume 12, Issue 1, Pages 29
出版商
MDPI AG
发表日期
2020-01-04
DOI
10.3390/pharmaceutics12010029
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Solid nanoparticles for oral antimicrobial drug delivery: a review
- (2019) Aun Raza et al. DRUG DISCOVERY TODAY
- A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia
- (2019) Ermias Diro et al. PLoS Neglected Tropical Diseases
- The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
- (2019) Grace Cuddihy et al. Pharmaceutics
- Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
- (2019) Xuemei Ge et al. Pharmaceutics
- Formulation and Characterization of a Self-nanoemulsifying Drug Delivery System of Amphotericin B for the Treatment of Leishmaniasis
- (2019) Momin Khan et al. IET Nanobiotechnology
- Antifungal and Mucoadhesive Properties of an Orally Administered Chitosan-Coated Amphotericin B Nanostructured Lipid Carrier (NLC)
- (2019) Janet Tan Sui Ling et al. AAPS PHARMSCITECH
- Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B
- (2019) Andreas H Groll et al. CLINICAL INFECTIOUS DISEASES
- Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
- (2019) Jill Adler-Moore et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
- (2019) R. Lu et al. mBio
- Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform
- (2019) Ruwandi Kariyawasam et al. BMC INFECTIOUS DISEASES
- Nanocapsules of Sterculia striata acetylated polysaccharide as a potential monomeric amphotericin B delivery matrix
- (2019) Fernanda Matoso Sombra et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Critical process parameters in manufacturing of liposomal formulations of amphotericin B
- (2019) Benjamin Rivnay et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models
- (2019) Faisal Usman et al. Drug Delivery and Translational Research
- Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases
- (2019) Juliane S. Lanza et al. Expert Opinion on Drug Delivery
- Improved Oral Bioavailability and Gastrointestinal Stability of Amphotericin B through Fatty Acid Conjugation Approach
- (2019) Kaushik Thanki et al. MOLECULAR PHARMACEUTICS
- Lyotropic Liquid Crystalline Nanoparticles of Amphotericin B: Implication of Phytantriol and Glyceryl Monooleate on Bioavailability Enhancement
- (2018) Sanyog Jain et al. AAPS PHARMSCITECH
- Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier
- (2018) Faisal Usman et al. AAPS PHARMSCITECH
- Evaluation of Amphotericin B Lipid Formulations for Treatment of Severe Coccidioidomycosis
- (2018) Ritam Sidhu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations
- (2018) Eden C. Andrew et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Safety and Effectiveness of Short-Course AmBisome in the Treatment of Post–Kala-Azar Dermal Leishmaniasis: A Prospective Cohort Study in Bangladesh
- (2018) Margriet den Boer et al. CLINICAL INFECTIOUS DISEASES
- Amphotericin B for treatment of visceral leishmaniasis: systematic review and meta-analysis of prospective comparative clinical studies including dose-ranging studies
- (2018) C. Rodrigo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Dual alginate-lipid nanocarriers as oral delivery systems for amphotericin B
- (2018) Juliana Perdiz Senna et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Long chain fatty acid conjugation remarkably decreases the aggregation induced toxicity of Amphotericin B
- (2018) Kaushik Thanki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Liquid crystalline drug delivery vehicles for oral and IV/subcutaneous administration of poorly soluble (and soluble) drugs
- (2018) Andrew Otte et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Development and in vitro evaluation of cost effective amphotericin B polymeric emulsion
- (2018) Zo-Ain Ishaq et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Cost-effectiveness of amphotericin B formulations in the treatment of systemic fungal infections
- (2018) Helena Hiemisch Lobo Borba et al. MYCOSES
- Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs
- (2018) J. Nieto et al. RESEARCH IN VETERINARY SCIENCE
- The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles
- (2018) Louise Walker et al. mBio
- Searching for a change: The need for increased support for public health and research on fungal diseases
- (2018) Marcio L. Rodrigues et al. PLoS Neglected Tropical Diseases
- Safety and Efficacy of High-Dose Infusions of a Preformed Amphotericin B Fat Emulsion for Treatment of Indian Visceral Leishmaniasis
- (2018) S. Sundar et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Comparative studies on amphotericin B nanosuspensions prepared by a high pressure homogenization method and an antisolvent precipitation method
- (2018) Yixian Zhou et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsion
- (2018) Andreza Rochelle do Vale Morais et al. EXPERIMENTAL PARASITOLOGY
- Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection
- (2018) Koichi Fujimoto et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Mechanism of Binding of Antifungal Antibiotic Amphotericin B to Lipid Membranes: An Insight from Combined Single-Membrane Imaging, Microspectroscopy, and Molecular Dynamics
- (2018) Ewa Grela et al. MOLECULAR PHARMACEUTICS
- Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B
- (2018) Janet Sui Ling Tan et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Imaging of human cells exposed to an antifungal antibiotic amphotericin B reveals the mechanisms associated with the drug toxicity and cell defence
- (2018) Ewa Grela et al. Scientific Reports
- A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia
- (2018) Liliana López et al. PLoS Neglected Tropical Diseases
- Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release
- (2018) Aldemar Gordillo-Galeano et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Development of a flow-through USP 4 apparatus drug release assay for the evaluation of amphotericin B liposome
- (2018) Jie Tang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Nanostructured lipid carriers containing Amphotericin B: Development, in vitro release assay, and storage stability
- (2018) Rosilene Rodrigues Santiago et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Permeability Characteristics of a New Antifungal Topical Amphotericin B Formulation with γ-Cyclodextrins
- (2018) Carmen López-Castillo et al. MOLECULES
- Fungal persister cells: The basis for recalcitrant infections?
- (2018) Jurgen Wuyts et al. PLoS Pathogens
- Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems
- (2018) Vijay Mishra et al. Pharmaceutics
- Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B
- (2018) Zhimei Song et al. CARBOHYDRATE POLYMERS
- ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans
- (2017) José P. Guirao-Abad et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Correlating gastric emptying of amphotericin B and paracetamol solid lipid nanoparticles with changes in particle surface chemistry
- (2017) Hilda Amekyeh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Multi-Phase Solvation Model for Biological Membranes: Molecular Action Mechanism of Amphotericin B
- (2017) J. M. Falcón-González et al. Journal of Chemical Theory and Computation
- Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis
- (2017) Fernanda S. Tonin et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Neglected endemic mycoses
- (2017) Flavio Queiroz-Telles et al. LANCET INFECTIOUS DISEASES
- Amphotericin B releasing topical nanoemulsion for the treatment of candidiasis and aspergillosis
- (2017) Lilian Sosa et al. Nanomedicine-Nanotechnology Biology and Medicine
- New perspectives in the topical delivery of optimized amphotericin B loaded nanoemulsions using excipients with innate anti-fungal activities: A mechanistic and histopathological investigation
- (2017) Afzal Hussain et al. Nanomedicine-Nanotechnology Biology and Medicine
- Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
- (2017) Ridwanur Rahman et al. PLoS Neglected Tropical Diseases
- Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally
- (2017) Anuradha Chowdhary et al. PLoS Pathogens
- Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B
- (2017) Md. Shadab et al. PLoS One
- Surface-Modified Liposomal Formulation of Amphotericin B: In vitro Evaluation of Potential Against Visceral Leishmaniasis
- (2016) Shilpa N. Patere et al. AAPS PHARMSCITECH
- Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species
- (2016) Abdullah M. S. Al-Hatmi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
- (2016) Shawn R. Lockhart et al. CLINICAL INFECTIOUS DISEASES
- Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro
- (2016) Ana Paula Perez et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Topical Amphotericin B solid lipid nanoparticles: Design and development
- (2016) Dhruv Butani et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Exploring The Role Of Nanoparticles In Amphotericin B Delivery
- (2016) Soraia Zaioncz et al. CURRENT PHARMACEUTICAL DESIGN
- Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index
- (2016) Qamar Zia et al. CURRENT PHARMACEUTICAL DESIGN
- Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B
- (2016) Afzal Hussain et al. DRUG DELIVERY
- Nosocomial Fungal Infections
- (2016) Geehan Suleyman et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Antifungal Agents
- (2016) Jeniel E. Nett et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- The Global Burden of Fungal Diseases
- (2016) Snigdha Vallabhaneni et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii
- (2016) A. Batista-Duharte et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Chitosan/ Sterculia striata polysaccharides nanocomplex as a potential chloroquine drug release device
- (2016) Guilherme A. Magalhães Jr. et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Lipoamino acid-based micelles as promising delivery vehicles for monomeric amphotericin B
- (2016) Cláudia Serafim et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy
- (2016) Tian Fu et al. JOURNAL OF LIPOSOME RESEARCH
- Membrane Sterols Modulate the Binding Mode of Amphotericin B without Affecting Its Affinity for a Lipid Bilayer
- (2016) Anna Neumann et al. LANGMUIR
- Comparison between liposomal formulations of amphotericin B
- (2016) Jill P Adler-Moore et al. MEDICAL MYCOLOGY
- The fungicidal activity of amphotericin B requires autophagy-dependent targeting to the vacuole under a nutrient-starved condition in Saccharomyces cerevisiae
- (2016) Michiru Yoshioka et al. MICROBIOLOGY-SGM
- Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis
- (2016) Laiza M. Steimbach et al. MYCOSES
- Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B
- (2016) Celeste Alvarez et al. PHARMACEUTICAL RESEARCH
- Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth
- (2016) Farazul Haque et al. Scientific Reports
- Molecular organization, localization and orientation of antifungal antibiotic amphotericin B in a single lipid bilayer
- (2016) Wojciech Grudzinski et al. Scientific Reports
- Effect of Food Status on the Gastrointestinal Transit of Amphotericin B-Containing Solid Lipid Nanoparticles in Rats
- (2015) Hilda Amekyeh et al. AAPS PHARMSCITECH
- A Gastrointestinal Transit Study on Amphotericin B-Loaded Solid Lipid Nanoparticles in Rats
- (2015) Hilda Amekyeh et al. AAPS PHARMSCITECH
- Factors Affecting Enhanced Permeation of Amphotericin B Across Cell Membranes and Safety of Formulation
- (2015) Kajiram Adhikari et al. AAPS PHARMSCITECH
- In VitroActivities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates
- (2015) Anuradha Chowdhary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Taming Amphotericin B
- (2015) Vaclav Janout et al. BIOCONJUGATE CHEMISTRY
- Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B
- (2015) Mohammad Asad et al. BMC INFECTIOUS DISEASES
- Solubilization power of an amino acid-based gemini surfactant towards the hydrophobic drug amphotericin B
- (2015) Célia Faustino et al. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
- Candida tropicalis biofilm's matrix—involvement on its resistance to amphotericin B
- (2015) Tânia Fernandes et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- A new look at the antibiotic amphotericin B effect on Candida albicans plasma membrane permeability and cell viability functions
- (2015) Barbara Chudzik et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Nanoemulsions loaded with amphotericin B: A new approach for the treatment of leishmaniasis
- (2015) Leila Rodrigues Caldeira et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Th-1 biased immunomodulation and synergistic antileishmanial activity of stable cationic lipid–polymer hybrid nanoparticle: Biodistribution and toxicity assessment of encapsulated amphotericin B
- (2015) Shalini Asthana et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application
- (2015) Yashpal S. Chhonker et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles
- (2015) Ming-Thau Sheu et al. International Journal of Nanomedicine
- Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections
- (2015) Ana C. Moreno-Rodríguez et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms
- (2015) Akira Kawai et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Neutron Scattering Studies of the Effects of Formulating Amphotericin B with Cholesteryl Sulfate on the Drug’s Interactions with Phospholipid and Phospholipid–Sterol Membranes
- (2015) F. Foglia et al. LANGMUIR
- Antifungal antibiotics modulate the pro-inflammatory cytokine production and phagocytic activity of human monocytes in an in vitro sepsis model
- (2015) Stefan Muenster et al. LIFE SCIENCES
- Development and characterization of oral liposomes of vegetal ceramide based amphotericin B having enhanced dry solubility and solubility
- (2015) Malika Skiba-Lahiani et al. Materials Science & Engineering C-Materials for Biological Applications
- Oral Particle Uptake and Organ Targeting Drives the Activity of Amphotericin B Nanoparticles
- (2015) Dolores R. Serrano et al. MOLECULAR PHARMACEUTICS
- Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study
- (2015) Diego R. Falci et al. MYCOSES
- 10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology ofAspergillusspp. infection in lung transplantation
- (2015) Maddalena Peghin et al. TRANSPLANT INTERNATIONAL
- Development and Characterization of Spray Dried Microparticles for Pulmonary Delivery of Antifungal Drug
- (2015) Divita Mathpal et al. Current Drug Delivery
- Solid lipid nanoparticles of amphotericin B (AmbiOnp): in vitro and in vivo assessment towards safe and effective oral treatment module
- (2015) Manisha B. Chaudhari et al. Drug Delivery and Translational Research
- The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug
- (2014) Ana Cecilia Mesa-Arango et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Long-term sustained-releasedin situgels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation,in vitroandin vivoevaluation
- (2014) Guo Shan-Bin et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B
- (2014) Afzal Hussain et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperature
- (2014) Kishor M. Wasan et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments
- (2014) Daniel Michał Kamiński EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection
- (2014) Ping Xu et al. International Journal of Nanomedicine
- Study of amphotericin B magnetic liposomes for brain targeting
- (2014) Mengyu Zhao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation
- (2014) Katkam N. Gangadhar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanoethosomal formulation for skin targeting of amphotericin B: anin vitroandin vivoassessment
- (2014) Lakhvir Kaur et al. JOURNAL OF LIPOSOME RESEARCH
- In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates
- (2014) M. T. Montagna et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Self-Association of Amphotericin B: Spontaneous Formation of Molecular Structures Responsible for the Toxic Side Effects of the Antibiotic
- (2014) Joanna Starzyk et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice
- (2014) J. A. Olson et al. MEDICAL MYCOLOGY
- Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method
- (2014) F. D. Rojas et al. MEDICAL MYCOLOGY
- Amphotericin forms an extramembranous and fungicidal sterol sponge
- (2014) Thomas M Anderson et al. Nature Chemical Biology
- Fungal Biofilms, Drug Resistance, and Recurrent Infection
- (2014) J. V. Desai et al. Cold Spring Harbor Perspectives in Medicine
- Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study
- (2014) Shyam Sundar et al. PLoS Neglected Tropical Diseases
- Properties of An Oral Nanoformulation of A Molecularly Dispersed Amphotericin B Comprising A Composite Matrix of Theobroma Oil and Bee’S Wax
- (2014) Chloe Tan et al. Nanomaterials
- Antifungal Lock Therapy With Liposomal Amphotericin B: A Prospective Trial
- (2014) William McGhee et al. Journal of the Pediatric Infectious Diseases Society
- Lipid Effects on Expulsion Rate of Amphotericin B from Solid Lipid Nanoparticles
- (2013) See Wei Tan et al. AAPS PHARMSCITECH
- Niosomes from 80s to present: The state of the art
- (2013) Carlotta Marianecci et al. ADVANCES IN COLLOID AND INTERFACE SCIENCE
- Successful Treatment of Pulmonary Blastomycosis with Continuously Infused Amphotericin B Deoxycholate After Failure with Liposomal Amphotericin B
- (2013) Robert E Ariano et al. ANNALS OF PHARMACOTHERAPY
- New Insight into Amphotericin B Resistance in Aspergillus terreus
- (2013) Gerhard Blum et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
- (2013) Richard J. Hamill DRUGS
- Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B
- (2013) Angela S Loo et al. Expert Opinion On Drug Safety
- NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency
- (2013) Michael Oda et al. International Journal of Nanomedicine
- An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity
- (2013) L. Y. A. Chai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Alteration in cellular viability, pro-inflammatory cytokines and nitric oxide production in nephrotoxicity generation by Amphotericin B: involvement of PKA pathway signaling
- (2013) F. D. França et al. JOURNAL OF APPLIED TOXICOLOGY
- Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant
- (2013) Victor Monforte et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasis
- (2013) Fady Ibrahim et al. Lipids in Health and Disease
- Development of Amphotericin B-Loaded Cubosomes Through the SolEmuls Technology for Enhancing the Oral Bioavailability
- (2012) Zhiwen Yang et al. AAPS PHARMSCITECH
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Pharmacokinetics of Amphotericin B Colloidal Dispersion in Critically Ill Patients with Cholestatic Liver Disease
- (2012) Stefan Weiler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacious Treatment of Non-Dermatophyte Mould Onychomycosis with Topical Amphotericin B
- (2012) Massimo Lurati et al. DERMATOLOGY
- Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis model
- (2012) Fady Ibrahim et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis
- (2012) Alexandra F. Gazzoni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- How can micelle systems be rebuilt by a heating process?
- (2012) Eryvaldo Egito et al. International Journal of Nanomedicine
- Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis
- (2012) W. R. Kirkpatrick et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Amphotericin B-Loaded Nanocarriers for Topical Treatment of Cutaneous Leishmaniasis: Development, Characterization, and In Vitro Skin Permeation Studies
- (2012) Journal of Biomedical Nanotechnology
- The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection
- (2012) M. Alsaadi et al. JOURNAL OF CONTROLLED RELEASE
- Toward Understanding of Toxic Side Effects of a Polyene Antibiotic Amphotericin B: Fluorescence Spectroscopy Reveals Widespread Formation of the Specific Supramolecular Structures of the Drug
- (2012) Piotr Wasko et al. MOLECULAR PHARMACEUTICS
- Amphotericin primarily kills yeast by simply binding ergosterol
- (2012) K. C. Gray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
- (2012) Ana C. Mesa-Arango et al. Frontiers in Microbiology
- A novel mechanism for an old drug: Amphotericin B in the treatment of visceral leishmaniasis
- (2011) Amitabha Chattopadhyay et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a distigmasterylhemisuccinoyl-glycero-phosphocholine liposome-intercalated amphotericin B
- (2011) Maryam Iman et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- AmbiOnp: Solid Lipid Nanoparticles of Amphotericin B for Oral Administration
- (2011) Pratikkumar A. Patel et al. Journal of Biomedical Nanotechnology
- Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
- (2011) Shyam Sundar et al. LANCET
- Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model
- (2011) Olena Sivak et al. Lipids in Health and Disease
- In vitro activity of amphotericin B cochleates against Leishmania chagasi
- (2011) Aretha Molina Sesana et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst
- (2011) Fernanda Sangalli-Leite et al. MICROBES AND INFECTION
- A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14 -Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B
- (2010) C. M. Martel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nanosomal Amphotericin B is an efficacious alternative to Ambisome® for fungal therapy
- (2010) Saifuddin Sheikh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A new vaginal delivery system of amphotericin B: a dispersion of cationic liposomes in a thermosensitive gel
- (2010) June-Woo Kang et al. JOURNAL OF DRUG TARGETING
- Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogenTrichosporonisolated from Turkish patients
- (2010) Ayse Kalkanci et al. MEDICAL MYCOLOGY
- Intrapulmonary Disposition of Amphotericin B After Aerosolized Delivery of Amphotericin B Lipid Complex (Abelcet; ABLC) in Lung Transplant Recipients
- (2010) Shahid Husain et al. TRANSPLANTATION
- A Novel Tropically Stable Oral Amphotericin B Formulation (iCo-010) Exhibits Efficacy against Visceral Leishmaniasis in a Murine Model
- (2010) Ellen K. Wasan et al. PLoS Neglected Tropical Diseases
- Amphotericin B-Induced Renal Tubular Cell Injury Is Mediated by Na+ Influx through Ion-Permeable Pores and Subsequent Activation of Mitogen-Activated Protein Kinases and Elevation of Intracellular Ca2+ Concentration
- (2009) T. Yano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of antifungals against Zygomycetes
- (2009) A. Alastruey-Izquierdo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Differences in human phospholipid transfer protein activity following incubation of Fungizone® compared to lipid-based Amphotericin-B formulations in normolipidemic and hyperlipidemic plasma
- (2009) Ryan J. Henderson et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Development and characterization of oral lipid-based Amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans
- (2009) Ellen K. Wasan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety
- (2009) Víctor Monforte et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- MICs and minimum fungicidal concentrations of amphotericin B, itraconazole, posaconazole and terbinafine in Sporothrix schenckii
- (2009) C. Pereira Silveira et al. JOURNAL OF MEDICAL MICROBIOLOGY
- On the Possibility of the Amphotericin B-Sterol Complex Formation in Cholesterol- and Ergosterol-Containing Lipid Bilayers: A Molecular Dynamics Study
- (2009) Anna Neumann et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Treatment of Central Venous Catheter Fungal Infection Using Liposomal Amphotericin-B Lock Therapy
- (2009) Bradley S. Buckler et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Amphotericin B: side effects and toxicity
- (2009) Rafael Laniado-Laborín et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Complex Formation of Amphotericin B in Sterol-Containing Membranes As Evidenced by Surface Plasmon Resonance†
- (2008) Ryota Mouri et al. BIOCHEMISTRY
- Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial
- (2008) Bart J. Rijnders et al. CLINICAL INFECTIOUS DISEASES
- In vitro susceptibility of Cryptococcus gattii clinical isolates
- (2008) A. Gomez-Lopez et al. CLINICAL MICROBIOLOGY AND INFECTION
- Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms
- (2008) Pranab K. Mukherjee et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effect of aggregation state on the toxicity of different amphotericin B preparations
- (2008) Raquel Espada et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC®: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry
- (2008) David L. Paterson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Amphotericin B Formulations and Drug Targeting
- (2007) J.J. Torrado et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Effect of Cholesterol on the Release of Amphotericin B from PEG-Phospholipid Micelles
- (2007) Ronak Vakil et al. MOLECULAR PHARMACEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started